Total Payments
$470,632
2024 Payments
$69,226
Companies
45
Transactions
1,232
Medicare Patients
17
Medicare Billing
$1,833
Payment Breakdown by Category
Other$305,799 (65.0%)
Travel$56,686 (12.0%)
Consulting$49,915 (10.6%)
Research$34,436 (7.3%)
Food & Beverage$23,562 (5.0%)
Education$234.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $305,799 | 144 | 65.0% |
| Travel and Lodging | $56,686 | 134 | 12.0% |
| Consulting Fee | $49,915 | 9 | 10.6% |
| Unspecified | $34,436 | 22 | 7.3% |
| Food and Beverage | $23,562 | 918 | 5.0% |
| Education | $234.72 | 5 | 0.0% |
Payments by Type
General
$436,196
1,210 transactions
Research
$34,436
22 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $373,990 | 442 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $33,174 | 16 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $18,403 | 71 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $10,748 | 75 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $8,296 | 57 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $5,754 | 3 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $4,566 | 8 | $0 (2021) |
| ITI, Inc. | $3,831 | 54 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $2,848 | 68 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,336 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69,226 | 150 | Janssen Pharmaceuticals, Inc ($66,071) |
| 2023 | $106,794 | 321 | Janssen Pharmaceuticals, Inc ($99,243) |
| 2022 | $66,996 | 173 | Janssen Pharmaceuticals, Inc ($65,118) |
| 2021 | $27,942 | 43 | Janssen Pharmaceuticals, Inc ($21,959) |
| 2020 | $26,726 | 58 | Janssen Pharmaceuticals, Inc ($21,559) |
| 2019 | $85,778 | 198 | Janssen Pharmaceuticals, Inc ($82,474) |
| 2018 | $37,664 | 149 | Neurocrine Biosciences, Inc. ($17,463) |
| 2017 | $49,507 | 140 | ACADIA Pharmaceuticals Inc ($19,602) |
All Payment Transactions
1,232 individual payment records from CMS Open Payments — Page 1 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Neuropsychiatry | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Opioid Analgesic | ||||||
| 11/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: PAIN | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $3,815.00 | General |
| Category: Neuroscience | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: Neuroscience | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: PAIN | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $11,445.00 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-038 | ACADIA Pharmaceuticals Inc | $21,007 | 9 |
| ACP-103-035 | ACADIA Pharmaceuticals Inc | $12,092 | 6 |
| Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,336 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 17 | 17 | $4,624 | $1,833 |
Total Patients
17
Total Services
17
Medicare Billing
$1,833
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | Office | 2020 | 17 | 17 | $4,624 | $1,833 | 39.6% |
About Dr. Robert Millet, M.D
Dr. Robert Millet, M.D is a Psychiatry healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134168347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Millet, M.D has received a total of $470,632 in payments from pharmaceutical and medical device companies, with $69,226 received in 2024. These payments were reported across 1,232 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($305,799).
As a Medicare-enrolled provider, Millet has provided services to 17 Medicare beneficiaries, totaling 17 services with total Medicare billing of $1,833. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Raleigh, NC
- Active Since 06/05/2006
- Last Updated 04/25/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1134168347
Products in Payments
- SPRAVATO (Drug) $331,964
- INVEGA SUSTENNA (Drug) $34,185
- NUPLAZID (Drug) $33,174
- INGREZZA (Drug) $18,403
- INVEGA TRINZA (Drug) $13,596
- ABILIFY MAINTENA (Drug) $9,979
- AUSTEDO (Drug) $4,085
- CAPLYTA (Drug) $4,082
- LATUDA (Drug) $2,848
- REXULTI (Drug) $2,675
- VRAYLAR (Drug) $1,181
- SD809-TD (Drug) $887.32
- ARISTADA (Drug) $671.58
- Aristada 441 mg (Drug) $560.51
- NUEDEXTA (Drug) $270.64
- QULIPTA (Drug) $240.71
- TRINTELLIX (Drug) $233.91
- Sunosi (Drug) $230.79
- Azstarys (Drug) $221.19
- XTAMPZA (Drug) $200.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Raleigh
Richard Weisler, M.d, M.D
Psychiatry — Payments: $1.9M
Psychiatry $1.9M
Ashwin Patkar, M.d, M.D
Psychiatry — Payments: $220,429
Psychiatry $220,429
Dr. Mona Gupta, D.o, D.O
Psychiatry — Payments: $133,268
Psychiatry $133,268
Dr. Celso Lobao, Md, MD
Psychiatry — Payments: $29,047
Psychiatry $29,047
Myleme Harrison, M.d, M.D
Psychiatry — Payments: $13,922
Psychiatry $13,922
Kellie Tolin, Md, MD
Psychiatry — Payments: $12,767
Psychiatry $12,767